Is There a New Mechanism for Treating Depression?
The study, conducted by researchers at the Icahn School of Medicine at Mount Sinai, used the drug ezogabine to open the KCNQ2/3 potassium channels in participants’ brains. The results showed significant improvements in depressive symptoms and anhedonia.1 Because anhedonia is associated with poor response to antidepressant medication, worse overall outcomes, and increased suicide risk, this […]
Is There a New Mechanism for Treating Depression? Read More »